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Renal artery stenosis or occlusion can manifest as
refractory hypertension, progressive renal insuffi-
ciency, or both.1,2 Issues regarding bilateral renal
artery stenoses/occlusions and solitary functioning
kidneys become paramount when evaluating the
efficacy of classical surgical management versus
endovascular management of renovascular lesions.3
Once Weibull et al4 established that the results of the
endovascular technique were potentially equivalent
to classical surgical management of renal artery
lesions, more specific questions arose regarding the
endovascular approach. Percutaneous transluminal
angioplasty (PTA) with or without stenting, type of
stent use, and clinical endpoint discernment issues
are just a few of the areas currently being evaluated
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From January 1993 to May 1996, 108 patients (64 men, 44 women; mean age, 72 years;
age range, 37 to 87 years) underwent 125 percutaneous transluminal angioplasties and
stent implantations primarily for atherosclerotic lesions of the renal artery. Sixty-four
patients underwent treatment for renovascular hypertension (two antihypertensive med-
ications or more), 32 patients underwent treatment for a combination of hypertension
and renal failure (serum creatinine level ‡ 1.6 mg/dL), and a small group of six patients
(5%) without hypertension or diminished renal function underwent treatment to pre-
vent the progression to renal artery occlusion and kidney loss. Thirty-three patients
(31%) had renovascular hypertension that was classified as severe on three or more med-
ications, 31 patients (29%) had renovascular hypertension that was classified as moder-
ate on two medications, and 38 patients (35%) had renovascular hypertension that was
classified in the mild group on a single antihypertensive agent. Stenotic lesions were
located at the ostium of the renal artery in 82 cases (65%) and were ostial-adjacent (<5
mm from renal ostium) in the other 43 cases (34%). A total of 125 stents were deployed
in 125 arteries (procedural success 97.6%). Renovascular hypertension either was cured
or was improved in 73 patients (68%), with 14 patients (13%) considered cured (nor-
motensive on no medications). The conditions of 29 patients (27%) were unchanged,
and 6 patients (5%) had worsening hypertension after surgery. We were unable to
demonstrate a statistically significant improvement in serum creatinine levels after renal
artery balloon angioplasty/stenting. Complications occurred in a total of nine cases
(7.2%), six of which were related to technical problems. One patient had worsening renal
insufficiency caused by contrast agent, and another patient had a perinephric hematoma
develop that necessitated evacuation. There were four postoperative deaths (30-day mor-
tality). Two of these deaths were caused by postoperative myocardial infarction. The
other two patients had progressive renal failure develop that necessitated dialysis. These
patients later died of the disease process despite supportive care. Follow-up renal artery
duplex scan studies and angiograms were available on 96 patients (76%). The mean peak
systolic renal/aortic ratio on duplex scanning was 2.2. Life-table analysis yielded a 74%
primary patency rate and an 85% secondary patency rate at 36 months. This retrospec-
tive analysis showed the effectiveness of combining percutaneous transluminal angio-
plasty with stent deployment for significant renal artery stenosis to treat renovascular
hypertension. (J Vasc Surg 1999;29:617-24.)
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in clinical trials.5,6 Gosset and Olin7 prospectively
studied 395 consecutive patients who underwent
angiography for peripheral vascular disease. They
suggested that atherosclerotic renovascular disease
should be suspected in any patient with a new onset
of diastolic hypertension after the age of 55 years.
They stated that elderly patients with either resistant
or malignant-phase hypertension have renal artery
disease until proven otherwise.7 Zierler et al8 used
renal duplex ultrasound scanning to prospectively
study the anatomic progression of atherosclerotic
renovascular disease at set intervals. They made the
following conclusions: if the renal arteries were nor-
mal, the rate of disease progression was low; at 3
years, lesions in 48% of the patients advanced from
<60% stenosis to ‡ 60% stenosis; and the four renal
arteries that progressed to occlusion had ‡ 60%
stenosis initially.8,9 These issues, in conjunction with
our vast patient population, fostered our interest in
the evaluation of early and long-term follow-up of
renal artery stenosis treated with PTA and routine
stent deployment.
MATERIALS AND METHODS
Patients. From January 1993 to May 1996,
108 patients (64 men, 44 women; mean age, 72
years; age range, 37 to 87 years) underwent 125 bal-
loon angioplasties and stenting of the renal arteries.
The study comprised all the consecutive renal stent
cases that were performed during this period. The
renal fibromuscular dysplasia cases that were treated
with balloon angioplasty alone were excluded from
the study. Each patient underwent preoperative
renal artery duplex scanning, angiography, or both,
which were used to determine percent stenosis and
endovascular candidacy. Sixty-four patients (59%)
underwent treatment for renovascular hypertension,
32 patients (29%) underwent treatment for a combi-
nation of hypertension and renal failure (serum cre-
atinine level, ‡ 1.6 mg/dL), and a small group of six
patients (5%) without hypertension or diminished
renal function underwent treatment to prevent pro-
gression to renal artery occlusion and loss of a kid-
ney. These six lesions were identified during angiog-
raphy for other disease. Two cases had 70% stenosis,
and four of the cases had >80% renal artery ostial
stenosis. Clinical success at follow-up examination
was on the basis of the degree of restenosis rather
than the discontinuation of antihypertensive medica-
tions in this small subset of patients. The conditions
of 33 patients (31%) with renovascular hypertension
were classified as severe on three or more antihyper-
tensive medications, the conditions of 31 patients
(29%) were defined as moderate on two medica-
tions, and the conditions of 38 patients (35%) were
in the mild group on a single antihypertensive agent.
All the lesions were atherosclerotic in nature.
Technique. Before performing PTA/stenting of
the renal arteries, both renal arterial duplex scanning
and angiography were performed on all the patients.
Renal artery duplex scanning necessitated the use of a
low-frequency transducer (2 to 3 MHz). Before the
examination, the patients fasted overnight to decrease
the amount of bowel gas present. Color flow imaging
helped to identify the renal arteries. We kept the color
section box small to optimize the frame rate and to
minimize the temporal distortion. The pulsed Doppler
scan confirmed the identification of the renal arteries.
The normal renal artery peak systolic velocities were
104 ± 25 cm/s on the right and 93 ± 19 cm/s on the
left.10-12 An increase in the renal artery peak systolic
velocities was a reliable parameter to differentiate
between a healthy and a diseased artery. A value of a
more than 180-cm/s threshold could detect renal
arterial disease with an 84% sensitivity rate and a 97%
specificity rate, with an overall agreement rate with
angiography of 93%.13
The ratio of the renal artery peak systolic velocity
to the peak systolic velocity of the aorta is used to
identify high-grade stenotic lesions. This value is
known as the renal/aortic ratio. The severity of renal
artery stenosis is categorized by the criteria of char-
acteristics presented in Table I.14 A renal/aortic ratio
of 3.5 or more was found to be 84% to 92% sensitive
and 62% to 97% specific in the diagnosis of a hemo-
dynamically significant ( ‡ 60% diameter reducing)
renal artery stenosis (93% accuracy).13,14
The procedures were performed in the endovas-
cular suite with local anesthesia, which, in most of
the cases, was supplemented with intravenous seda-
tion per patient request. A transradial arterial line
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Table I. Preoperative and postoperative serum
creatinine levels (renal function)
Preoperative SCL Postoperative SCL
SCL (mg/dL) No. of cases No. of cases
≤1.5 84 98
1.6 to 2.0 16 13
2.1 to 2.5 10 2
2.6 to 3.0 6 1
‡ 3.0 8 10
Unknown 1 1
Mean SCL 2.0 mg/dL 1.8 mg/dL
SCL, Serum creatinine level.
was placed in all the cases for blood pressure moni-
toring. A percutaneous femoral retrograde approach
was used in 115 cases (92%), and a brachial approach
was used in 10 cases (8%).
A 9F sheath was used during the femoral approach
to accommodate an 8F guiding catheter (C-2, Cobra
head catheter, MediTech/Boston Scientific, Natick,
Mass). The guiding catheter aided in simplifying the
cannulation of the renal artery and in making the
delivery of the stent safer without losing the position
of the renal ostium. In the retrograde brachial
approach, a 7F sheath was used because of the small-
er average size of this artery. Systemic heparin was
used to maintain the activated coagulation time at
more than 250 seconds. The renal artery was cannu-
lated with a 180-cm (0.035-inch) angled hydrophilic
guidewire (Glidewire, MediTech/Boston Scientific),
and an angiogram was obtained through the guiding
catheter. The tip of the guidewire was kept within the
fluoroscopic telescope field at all times to avoid ante-
grade propulsion of the wire during catheter advance-
ment. A predilatation of the lesion with an angioplas-
ty balloon (range, 4 to 7 mm) was performed in all
the cases and was followed by a road-map angiogram.
An effort was made, while performing the angiogram
via the Cobra head catheter, to visualize a portion of
the aorta to clearly delineate the location of the renal
ostium.
A rigid balloon-expandable stent (Corolis
Endovascular, a Johnson and Johnson Co, Warren,
NJ) was used in all the cases (size range, 1.0 to 2.0
cm). In the cases of ostial stenosis, the stent was
deployed 1.0 to 2.0 mm into the aortic lumen and
then was flared up against the ostium with a balloon
catheter. Intraoperative angiography was performed
after the stent implantation, and repeat dilatation
with a larger balloon size was performed, only if
unsatisfactory results (ie, residual stenosis >30% after
balloon dilatation) were obtained in the initial
attempt.
After the procedure was completed, the patient
was transferred to the intensive care unit. The sheath
was removed when the activated coagulation time
was less than 150 seconds. Routinely, the patient was
discharged the following morning on daily aspirin
therapy.
Definition and follow-up period. Immediate
technical success was defined as adequate stent deploy-
ment at the appropriate site and a satisfactory angio-
graphic result (ie, no residual stenosis, dissection, or
extravasation of the contrast). The patients under-
went evaluation at different intervals during the fol-
low-up period. The diversity of the follow-up inter-
vals was largely because of the seasonal population
trends of our geographic territory. We encouraged
follow-up examination at the following intervals: 1
week, 3 and 6 months, and yearly with duplex scan
examination. A clinical interview with an analysis of
the trends of the systemic blood pressures was
recorded, and the reassessment of the number/doses
of the antihypertensive medications was performed.
Patency of the stented areas was shown with duplex
scan results, which measured the peak systolic veloc-
ities of the renal artery (PSVRA) and the aorta
(PSVA) and calculated the renal/aortic ratio. Stent
failure or restenosis was defined as a renal/aortic ratio
(PSVRA/PSVA) of more than 3.5 cm/s, which indi-
cated >60% stenosis.5,13,14 This was followed with
angiography to confirm the duplex scan findings.
Operative intervention was on the basis of the angio-
graphic findings. We described an “ostial adjacent
lesion” as being within 5 mm of the renal ostium.
Renovascular hypertension improvements were
categorized according to the reporting standards of a
cooperative study on renovascular hypertension.6 A
patient was considered cured (diastolic pressure, ≤90
mm Hg without medication), improved (decrease of
20 mm Hg in systolic blood pressure occurred while
the patient was on the same or less medication),
unchanged (the above-mentioned did not apply), or
worse (systolic blood pressure became uncontrolled
or another medication was added).
Cumulative patency rates were calculated with the
life-table analysis method as defined by the Ad Hoc
Subcommittee on Reporting Standards of the Society
for Vascular Surgery/North American Chapter of the
International Society of Cardiovascular Surgery.15
RESULTS
A total of 125 stents were deployed in 125 arter-
ies, with a procedural success rate of 97.6% (misplaced
stent relative to ostium in three cases) as determined
with absence of residual stenosis on completion intra-
operative angiography. All the stents were Palmaz
models: P104 (n = 22), P154 (n = 74), P204 (n =
30), and P254 (n = 1). Mean preoperative stenosis
was 83%, with significant contralateral stenosis or
occlusion present in 39 patients (35%).
Percutaneous access to the renal artery was either
retrograde femoral (n = 115) or retrograde brachial
(n = 10), with half of the cases performed with local
anesthesia with mild sedation. Stenotic lesions were
located at the ostium of the renal artery (Fig 1) in
82 cases (66%) and were ostial-adjacent (≤5 mm dis-
tance from renal ostium; Fig 2) in the other 43 dis-
eased vessels (34%). There were 17 patients (34
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arteries) with bilateral lesions that were treated
simultaneously, and two of the patients had accesso-
ry renal artery stenosis (Fig 3). The other 22
patients with contralateral stenosis underwent treat-
ment at a later date not included in these data. The
decision to simultaneously correct the contralateral
renal artery disease was a purely clinical judgment on
the basis of the degree of difficulty encountered with
the initial renal artery lesion.
Renovascular hypertension either was cured or
was improved in 73 patients (68%), with 14 patients
(11%) considered cured as defined by normotensive
with no antihypertensive medications. The condi-
tions of 29 patients remained unchanged, and six
patients demonstrated worsening hypertension.
Renal function stabilized without worsening in 105
patients (96%) on the basis of a mean preoperative
serum creatinine level of 2.0 mg/dL versus a level of
1.8 mg/dL after surgery. Five patients (4.5%) had
further deterioration of renal function, three of
them with pre-existing chronic renal failure change.
We did not identify statistically significant changes in
preoperative or postoperative serum creatinine lev-
els. The serum creatinine levels before and after the
procedure are compared in Table II.
Complications occurred in a total of nine patients
(7.2%), and six of these complications were techni-
cal. Major complications and death occurred in four
patients (3.2%). Two deaths were on the third post-
operative day and were caused by myocardial infarc-
tion in both the patients, ages 76 and 78 years.
There were two additional deaths that were caused
by the procedure. The first patient had a preopera-
tive creatinine level of 3.8 mg/dL and was adminis-
tered a large volume of contrast during the initial
diagnostic study, with additional contrast during the
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Fig 2. Typical nonostial (ostial-adjacent) lesion. A, Preoperative angiogram. B, Angiogram after
Palmaz stent P154 (1.5 cm) deployment.
Fig 1. Typical ostial lesion in hypertensive patient. A, Preoperative angiogram. B, Angiogram
after placement of Palmaz stent P154 (1.5 cm), dilated with a 6-mm balloon.
stent placement. This patient died 1 month later after
progressive renal failure that necessitated dialysis.
A perinephric hematoma that developed in the sec-
ond patient was related to wire placement and was
treated conservatively. This patient also had acute on
chronic renal failure develop and died 2 weeks later
of multiple system organ failure. One patient had a
retroperitoneal hematoma develop, and another had
a perinephric hematoma that necessitated evacua-
tion. One patient with brachial artery access had a
pseudoaneurysm develop, which was repaired suc-
cessfully.
Restenosis developed in six patients (5.5%), three
of whom had recurrent hypertension. Angiographic
results revealed proximal stent stenosis caused by the
misplacement of the initial stent distal to the renal
artery ostium in three of the patients. A second stent
was deployed to correct the problem. Two patients
had difficult renal ostial lesions, one of which failed
with two restenoses. Progressive diabetic nephropa-
thy developed in the other patient despite a patent
stent. The sixth patient’s condition was classified as
a failure solely on the basis of the duplex scan find-
ings without clinical symptomatology.
Clinical follow-up was obtained on all the patients
in the series. However, follow-up renal artery duplex
scan studies were performed on 96 of the patients
(76%). Sixteen of the patients also underwent angiog-
raphy that correlated with the duplex scan findings.
The mean peak systolic renal/aortic ratio on duplex
scanning was 2.2. Two patients had elevated
renal/aortic peak systolic velocity ratios without the
need for additional antihypertensive medications or
evidence of diminished renal function and were sub-
sequently followed clinically. None of the stents were
occluded. Life-table analysis yielded a 74% primary
patency rate and an 85% secondary cumulative paten-
cy rate at 36 months (Tables III, IV; Figs 4, 5).
DISCUSSION
Clinical suspicion is paramount in identifying
renal artery lesions because the initial presentation is
often subtle and progresses to a further degree of
renal insufficiency/failure or hypertensive sequel-
ae.16 We demonstrated improvement of renovascu-
lar hypertension in 68% of our patient population of
which 14% were able to discontinue all antihyper-
tensive medications. Numerous other series showed
a favorable reduction of antihypertensive methods
after the successful resolution of renal artery steno-
sis.17-23 However, in a contradistinction to our
series, Plouin et al24 noted cure rates in 50% of the
patients with fibrodysplastic stenosis but in only 19%
of those with atherosclerotic stenosis.
We also reported a 3.2% operative mortality rate.
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 4 Rodriguez-Lopez et al 621
Table II. Duplex classification of renal artery
stenosis
RA peak systolic Renal/aortic
Reduction in RA diameter velocity ratio
Normal <180 cm/s <3.5
<60% diameter reduction >180 cm/s <3.5
60% to 99% diameter reduction >180 cm/s >3.5
RA, Renal artery.
Fig 3. Left renal and accessory renal artery stenosis. A, Preoperative angiogram; tight lesion of
left renal artery (hardly visualized; arrow); 90% stenoses of accessory renal artery. B, Stenting of
upper renal artery with P-154 Palmaz stent; accessory renal ostial lesion still untreated (arrow).
C, Postoperative angiogram after deployment of one stent in each left renal artery.
This percentage is biased because many of our patients
who were referred for endovascular treatment of renal
artery stenosis had comorbid medical conditions that
prohibited conventional renal artery bypass grafting.
In terms of our operative mortality rate, the wors-
ening renal insufficiency from contrast load highlights
one of the potential risks of “minimally-invasive” oper-
ative intervention. Selective angiography via Cobra
head catheter helps to reduce the dye load. The peri-
nephric hematoma can best be avoided by keeping the
tip of the guidewire within the fluoroscopic telescope
field at all times and by avoiding antegrade propulsion
of the wire during catheter advancement. We now use
a less traumatic angiographic guidewire.
Another issue for debate is the use of PTA only
versus the combined use of PTA and stenting.
Baert25 states that renal artery stenting should be
reserved for those cases of postangioplasty residual
stenosis of greater than 30%. This was confirmed by
Sos et al26 who noted high rates of restenosis when
an immediate postangioplasty residual stenosis >30%
and a persistent pressure gradient through the lesion
occurred. There were 82 ostial lesions (66%) in our
series, all of which were treated with combination
balloon angioplasty/stenting. Plouin et al27 argue
that, although stent placement prevents elastic recoil,
it does not eliminate restenosis as a result of the pres-
ence of neointimal formation caused by intra-arterial
foreign body reaction. However, Graor28 stated that
such neointimal growth usually is limited to 1.0 to
1.5 mm and that it is important to expand the renal
artery and stent to at least 6 mm to accommodate
this phenomenon (Fig 6).
On the basis of our experience, we believe it is
easy to miss the ostium itself with a subsequent
higher rate of restenosis. The stent needs to be
placed 1 to 2 mm into the aortic lumen to cover the
renal ostium effectively. The proximal end of the
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Table III. Primary cumulative patency rates with life-table analysis
No. of grafts withdrawn patent
Interval No. of stents No. of failed No. of patients No. of Interval patency Cumulative patency Standard
(mo) at risk stents Duration lost to follow-up deaths rate rate (% ) error (%)
0 to 1 125 0 2 10 2 1 100 0
1 to 3 111 0 8 2 8 1 100 0
3 to 6 93 2 11 1 0 0.97 97 1.7
6 to 9 79 2 9 4 2 0.97 94 2.7
9 to 12 62 0 8 1 1 1 94 3.1
12 to 18 52 0 19 1 2 1 94 3.3
18 to 24 30 0 8 0 0 1 94 4.4
24 to 30 22 1 8 0 0 0.94 88 7.3
30 to 36 13 1 12 0 0 0.85 74 10.7
Type of operation was stent deployment at renal arteries.
Number of patients was 108, and number of stents was 125.
Fig 4. Graphic representation of primary cumulative patency rate.
stent also should be flared open with the balloon.
This is in accordance with Graor’s conclusion.28
The assessment of clinical/technical success neces-
sitates a well-defined endpoint for analysis. Our com-
prehensive follow-up examination included color flow
duplex scanning and angiography of the renal arteries
in 96 patients (76%) in addition to clinical examination
in all the patients. We used the ratio of the PSVRA and
the PSVA as an accurate and valuable means by which
to quantify degrees of restenosis in follow-up exami-
nation. If the renal/aortic ratio was greater than 3.5, a
>60% stenosis was to be expected and the outcome
was therefore classified as a failure in our series.5,29
We did not achieve a statistically significant
improvement in creatinine levels after the successful
resolution of the renal artery lesions. This is in accor-
dance with Blum et al21 and Plouin et al.24 However,
Boisclair et al30 reported improved creatinine levels
in seven of 17 patients (44%) after successful renal
artery lesion stenting. Perhaps future trials will delin-
eate whether one can expect improved postoperative
creatinine levels in patients with renal insufficiency.
In conclusion, this retrospective analysis shows
the effectiveness of combining percutaneous balloon
angioplasty with stent deployment for hemodynami-
cally significant renal artery stenosis to treat renovas-
cular hypertension. This also may have a role in the
salvage of renal function, although we were unable to
demonstrate this benefit. The value of the treatment
of renal artery stenosis >60% without hypertension or
diminished renal function will necessitate additional
knowledge about the natural history of untreated
lesions. The efficacy of combined PTA/stent place-
ment and the type of stent use (rigid vs flexible) can
only be determined with a comparison of the long-
term follow-up results of respective future series. The
standardization of endpoint results will be crucial if
analyses are to be meaningful.
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Fig 5. Graphic representation of secondary cumulative patency rate.
Table IV. Secondary cumulative patency rates with life-table analysis
No. of grafts withdrawn patent
Interval No. of stents No. of failed No. of patients No. of Interval patency Cumulative patency Standard
(mo) at risk stents Duration lost to follow-up deaths rate rate (% ) error (%)
0 to 1 125 0 2 10 2 1 100 0
1 to 3 111 0 8 2 8 1 100 0
3 to 6 93 2 11 1 0 0.97 97 1.7
6 to 9 79 0 9 4 2 1 97 1.9
9 to 12 64 0 8 1 1 1 97 2.1
12 to 18 54 0 19 1 2 1 97 2.3
18 to 24 32 0 9 0 0 1 97 3
24 to 30 23 0 8 0 0 1 97 3.6
30 to 36 15 1 14 0 0 0.88 85 10
Type of operation was stent deployment at renal arteries.
Number of patients was 108, and number of stents was 125.
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Fig 6. Follow-up examination at 22 months of left renal
artery stent in patient who is asymptomatic. Sign of inti-
mal hyperplasia in adequate preserved lumen is noted.
Renal/aortic ratio is 2.0.
